{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:49:54Z","timestamp":1787741394726,"version":"build-2784847793"},"reference-count":164,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Ther. Deliv."],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.4155\/tde-2019-0076","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T10:09:57Z","timestamp":1576490997000},"page":"833-850","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Advances in Delivery Vectors for Gene Therapy in Liver Cancer"],"prefix":"10.1080","volume":"11","author":[{"given":"Katherine E","family":"Redd Bowman","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics & Pharmaceutical Chemistry\rUniversity of Utah\rSalt Lake City\rUT\r84112\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phong","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics & Pharmaceutical Chemistry\rUniversity of Utah\rSalt Lake City\rUT\r84112\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica R","family":"Vander Mause","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics & Pharmaceutical Chemistry\rUniversity of Utah\rSalt Lake City\rUT\r84112\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol S","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics & Pharmaceutical Chemistry\rUniversity of Utah\rSalt Lake City\rUT\r84112\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2016.11.79"},{"key":"e_1_3_2_4_1","unstructured":"Institute NC . Cancer stat facts: Liver and intrahepatic bile duct cancer (2019). https:\/\/seer.cancer.gov\/statfacts\/html\/livibd.html"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i8.1020"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4557-2865-7.00080-1"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2017.11.050"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2013.04.015"},{"key":"e_1_3_2_10_1","first-page":"4711","article-title":"Delivery approaches of gene therapy in hepatocellular carcinoma","volume":"33","author":"Lam FDaMGEH","year":"2013","unstructured":"Lam FDaMGEH . Delivery approaches of gene therapy in hepatocellular carcinoma. Anticancer Res.33, 4711\u20134718 (2013).","journal-title":"Anticancer Res."},{"key":"e_1_3_2_11_1","first-page":"37","article-title":"Clinical therapeutic effect and biological monitoring of p53 gene in advanced hepatocellular carcinoma","author":"Chen S CJ","year":"2014","unstructured":"Chen S CJ , XiWet al. Clinical therapeutic effect and biological monitoring of p53 gene in advanced hepatocellular carcinoma. Am. J. Clin. Oncol. Rep.37 (2014).","journal-title":"Am. J. Clin. Oncol. Rep."},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e32832a2df9"},{"key":"e_1_3_2_13_1","first-page":"354","article-title":"Recombinant adenovirus-p53 gene therapy combined with transcatheter arterial chemoembolization for p53-positive and p53-negative hepatocellular carcinoma","volume":"7","author":"Ou SQ","year":"2010","unstructured":"Ou SQ , MYL , KangP , LiZK , MengZB , FQ. Recombinant adenovirus-p53 gene therapy combined with transcatheter arterial chemoembolization for p53-positive and p53-negative hepatocellular carcinoma. Chin. J. Interv. Imaging Ther.7, 354\u2013357 (2010).","journal-title":"Chin. J. Interv. Imaging Ther."},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i16.2143"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-009-0701-6"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i27.6127"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20268-6"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053072"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i27.6127"},{"issue":"3","key":"e_1_3_2_20_1","first-page":"282","article-title":"Combined use of chemotherapeutics and oncolytic adenovirus in treatment of AFP-expressing hepatocellular carcinoma","volume":"8","author":"Mao CY","year":"2009","unstructured":"Mao CY , HuaHJ , ChenP , YuDC , CaoJ , TengLS. Combined use of chemotherapeutics and oncolytic adenovirus in treatment of AFP-expressing hepatocellular carcinoma. Hepatobiliary Pancreat. Dis. Int.8(3), 282\u2013287 (2009).","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-018-0002-2"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17032"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2835"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2018.04.005"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29826"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2018.04.060"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160822"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2017-0028"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.05.017"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.15.43"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-017-0053-3"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/diseases6020042"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph5121372"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-5926-1-1"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302899"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-75-7-1749"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1106\/RA7U-1V9C-RV7C-8QXL"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1431927607070808"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2000.0227"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.04.029"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2011.265"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1408759111"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19123940"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05500-z"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.07.010"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7030066"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-015-0271-1"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.231"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050685"},{"issue":"2","key":"e_1_3_2_50_1","first-page":"1008","article-title":"Viral vector-based cancer immunotherapy","volume":"1","author":"Lundstrom K","year":"2016","unstructured":"Lundstrom K . Viral vector-based cancer immunotherapy. Austin Immunol.1(2), 1008 (2016).","journal-title":"Austin Immunol."},{"issue":"5","key":"e_1_3_2_51_1","first-page":"001","article-title":"Helper-dependent adenoviral vectors","author":"Rosewell A","year":"2011","unstructured":"Rosewell A , VetriniF , NgP. Helper-dependent adenoviral vectors. J. Genet. Syndr. Gene Ther. (Suppl. 5), 001 (2011).","journal-title":"J. Genet. Syndr. Gene Ther."},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2017.04.001"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.11.6"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1089\/10430340152712719"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2003.08.016"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2013.071"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1089\/10430340460732445"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.03.084"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2013.38"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.09.068"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2010.5"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0556"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27770"},{"key":"e_1_3_2_64_1","unstructured":"ClinicalTrials.gov. Identifier NCT02293850 Phase I study to evaluate the safety and efficacy of telomelysin (OBP-301) in patients with hepatocellular carcinoma (2014). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02293850"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2010.40"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.13621"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2014.1716"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3843"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-016-0353-8"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2017.86"},{"issue":"9","key":"e_1_3_2_71_1","first-page":"3395","article-title":"The development of conditionally replicative adenoviruses for cancer therapy","volume":"6","author":"Curiel DT","year":"2000","unstructured":"Curiel DT . The development of conditionally replicative adenoviruses for cancer therapy. Clin. Cancer Res.6(9), 3395 (2000).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950017725"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300728"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.06.009"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0697-639"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1750"},{"issue":"2","key":"e_1_3_2_77_1","first-page":"693","article-title":"Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies","volume":"9","author":"Makower D","year":"2003","unstructured":"Makower D , RozenblitA , KaufmanHet al. Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies. Clin. Cancer Res.9(2), 693 (2003).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_78_1","first-page":"1666","article-title":"[Phase III randomized clinical trial of intratumoral injection of E1B gene-deleted adenovirus (H101) combined with cisplatin-based chemotherapy in treating squamous cell cancer of head and neck or esophagus]","volume":"23","author":"Xia Z-J","year":"2004","unstructured":"Xia Z-J , ChangJ-H , ZhangLet al. [Phase III randomized clinical trial of intratumoral injection of E1B gene-deleted adenovirus (H101) combined with cisplatin-based chemotherapy in treating squamous cell cancer of head and neck or esophagus]. Chin. J. Cancer23, 1666\u20131670 (2004).","journal-title":"Chin. J. Cancer"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj111"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.3377"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700621"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2009.42.4.217"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa1405"},{"issue":"1","key":"e_1_3_2_84_1","first-page":"605","article-title":"Liver-directed gene therapy for hemophilia B with immune stealth lentiviral vectors","volume":"130","author":"Cantore A","year":"2017","unstructured":"Cantore A , MilaniM , AnnoniAet al. Liver-directed gene therapy for hemophilia B with immune stealth lentiviral vectors. Blood.130(Suppl 1), 605\u2013605 (2017).","journal-title":"Blood."},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2016.12.006"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01118"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0106-0"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2016.160"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2016.018"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2017.11.007"},{"key":"e_1_3_2_91_1","unstructured":"Medicine JoG . Gene Therapy Clinical Trials Worldwide (2017). www.abedia.com\/wiley\/"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2017.009"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2016.08.003"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.175"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2011.90"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.5.2420-2425.2000"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2018.07.011"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.05.003"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000380"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2019.01.008"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2015.89"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1039\/C4CC03292F"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.172"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.10.020"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12875"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.09.021"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2009.05.010"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.19893"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-013-0867-z"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.2147\/OV.S59640"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-virology-031413-085442"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S171269"},{"key":"e_1_3_2_113_1","article-title":"SillaJen remains confident about Pexa-Vec's value, despite trial failure","author":"Sae-im J","year":"2019","unstructured":"Sae-im J . SillaJen remains confident about Pexa-Vec's value, despite trial failure. Korea Biomed. Rev. (2019).","journal-title":"Korea Biomed. Rev."},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.2217\/fvl-2016-0028"},{"issue":"12","key":"e_1_3_2_115_1","article-title":"Self-Replicating RNA viruses for RNA therapeutics","volume":"23","author":"Lundstrom K","year":"2018","unstructured":"Lundstrom K . Self-Replicating RNA viruses for RNA therapeutics. Molecules (Basel).23(12) (2018).","journal-title":"Molecules (Basel)."},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2018.02.006"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i42.12022"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00971"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.03.384"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29513"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.1080\/1061186X.2017.1289536"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-016-0351-0"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2014.04.005"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.5b00601"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.02.027"},{"key":"e_1_3_2_126_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-018-0315-1"},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12541"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2014.02.003"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12465"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-6588-5_9"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2931813"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13697"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-015-0220-7"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S154458"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S154458"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.1039\/C7NR04425A"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/764706"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-582"},{"key":"e_1_3_2_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2014.03.026"},{"key":"e_1_3_2_140_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092721"},{"key":"e_1_3_2_141_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1231143"},{"key":"e_1_3_2_142_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3486"},{"key":"e_1_3_2_143_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1258096"},{"key":"e_1_3_2_144_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.052308.093131"},{"issue":"11","key":"e_1_3_2_145_1","first-page":"a012740","article-title":"Repair of strand breaks by homologous recombination","volume":"5","author":"Jasin M","unstructured":"Jasin M , RothsteinR. Repair of strand breaks by homologous recombination. CSH Perspect. Biol.5(11), a012740\u2013a012740).","journal-title":"CSH Perspect. Biol."},{"key":"e_1_3_2_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2007.02.006"},{"key":"e_1_3_2_147_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2015.2"},{"key":"e_1_3_2_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.08.021"},{"key":"e_1_3_2_149_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7104"},{"issue":"1","key":"e_1_3_2_150_1","first-page":"djw183","article-title":"Inactivation of cancer mutations utilizing CRISPR\/Cas9","volume":"109","author":"Gebler C","year":"2016","unstructured":"Gebler C , LohoffT , Paszkowski-RogaczMet al. Inactivation of cancer mutations utilizing CRISPR\/Cas9. J. Natl Cancer. Inst.109(1), djw183 (2016).","journal-title":"J. Natl Cancer. Inst."},{"key":"e_1_3_2_151_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10120481"},{"key":"e_1_3_2_152_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0538-7"},{"key":"e_1_3_2_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2018.10.002"},{"key":"e_1_3_2_154_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00449.2016"},{"key":"e_1_3_2_155_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.3055"},{"key":"e_1_3_2_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2015.06.026"},{"key":"e_1_3_2_157_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2295"},{"key":"e_1_3_2_158_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07642-6"},{"key":"e_1_3_2_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2018.05.006"},{"key":"e_1_3_2_160_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2017.209"},{"key":"e_1_3_2_161_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0892-2"},{"issue":"1","key":"e_1_3_2_162_1","first-page":"585","article-title":"Downregulation of YAP inhibits proliferation, invasion and increases cisplatin sensitivity in human hepatocellular carcinoma cells","volume":"16","author":"Wang X","year":"2018","unstructured":"Wang X , WuB , ZhongZ. Downregulation of YAP inhibits proliferation, invasion and increases cisplatin sensitivity in human hepatocellular carcinoma cells. Oncol. Lett.16(1), 585\u2013593 (2018).","journal-title":"Oncol. Lett."},{"key":"e_1_3_2_163_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.126"},{"key":"e_1_3_2_164_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14062"},{"key":"e_1_3_2_165_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-019-0514-4"},{"key":"e_1_3_2_166_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.9b00136"}],"container-title":["Therapeutic Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/tde-2019-0076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:17:01Z","timestamp":1715951821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/tde-2019-0076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,16]]},"references-count":164,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.4155\/tde-2019-0076"],"URL":"https:\/\/doi.org\/10.4155\/tde-2019-0076","relation":{},"ISSN":["2041-5990","2041-6008"],"issn-type":[{"value":"2041-5990","type":"print"},{"value":"2041-6008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-10-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}